Women's Folic Acid Levels Improving(berg School of Medicine Northwestern Uni...),Health
Navigation Links
Women's Folic Acid Levels Improving
Date:9/14/2007
berg School of Medicine, Northwestern University, Chicago; Tsunenobu Tamura, M.D., professor, nutrition sciences, University of Alabama at Birmingham; September 2007, American Journal of Clinical Nutrition
'/>"/>
| Copyright©2007 ScoutNews,LLC. All rights reserved |
Related medicine news :
1. Young womens woes
2. Cosmetic Genital Surgery may Be Fuelling Womens Insecurity About Their Bodies
3. Diabetic Womens Death Rate Shows No Decline
4. Rare Womens Lung Disease May Yield Insights Into Common Diseases
5. Womens Mood Plays a Key Role in Infertility Treatment
6. Folic Acid helps Kids with Diabetes
7. Folic Acid Found To Be Beneficial For Stroke Patients
8. The Importance Of Folic Acid Supplements
9. Folic Acid Supplementation During Pregnancy Could Help Prevent Spina Bifida
10. Folic Acid and Vitamin B12 Effective In Reducing The Risk Of Hip Fracture After Stroke
11. Pre-pregnancy folic acid intake does not increase rate of having twins
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting 2Health News:Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health 2Health News:Molecule Discovery Might Help ALS Patients 2Health News:Swine Flu Has Infected 1 in 6 Americans: CDC 2Health News:Swine Flu Has Infected 1 in 6 Americans: CDC 3Health News:Macomb County Announces New Location for Four Upcoming H1N1 Clinics 2
[1] Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting[0] Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health[0] Molecule Discovery Might Help ALS Patients[0] Swine Flu Has Infected 1 in 6 Americans: CDC[0] Macomb County Announces New Location for Four Upcoming H1N1 Clinics
Other Medicine News:Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:Study suggests human visual system could make powerful computer 2Health News:Study suggests human visual system could make powerful computer 3Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2
Misys Announces Preliminary Results for the Year Ended 31 May 2008MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management SystemCardiome Announces Preferred Share FinancingStudy suggests human visual system could make powerful computer$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, PennsylvaniaRock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon
Breaking Medicine Technology:Cambridge Scientists Archive 500,000th Crystal Structure 2New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Quest Diagnostics HemoCue AB Subsidiary to Add Avie 28TM 29 Hemoglobin A1c to Diabetes Point of Care Test Suite 47624 1Quest Diagnostics HemoCue AB Subsidiary to Add Avie 28TM 29 Hemoglobin A1c to Diabetes Point of Care Test Suite 47624 2Quest Diagnostics HemoCue AB Subsidiary to Add Avie 28TM 29 Hemoglobin A1c to Diabetes Point of Care Test Suite 47624 3Quest Diagnostics HemoCue AB Subsidiary to Add Avie 28TM 29 Hemoglobin A1c to Diabetes Point of Care Test Suite 47624 4Versus Technology Inc Announces Sale of Real Time Location Information System to the Chalmers P Wylie Veterans Clinic 47620 1Versus Technology Inc Announces Sale of Real Time Location Information System to the Chalmers P Wylie Veterans Clinic 47620 2Versus Technology Inc Announces Sale of Real Time Location Information System to the Chalmers P Wylie Veterans Clinic 47620 3Cynosure Announces Presentations at Upcoming Investor Conferences 12420 1Cynosure Announces Presentations at Upcoming Investor Conferences 12420 2
Other Medicine Technology:Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314 2Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314 3Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314 4Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkin's Lymphoma (NHL) 2Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkin's Lymphoma (NHL) 3Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkin's Lymphoma (NHL) 4Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkin's Lymphoma (NHL) 5
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |